Navigation Links
Clinical Study Published Showing Benefits of Glue Used in Facelift Surgery
Date:9/28/2007

BEVERLY HILLS, Calif., Sept. 28 /PRNewswire/ -- Dr. Davis B. Nguyen, M.D. announced today that his and Dr. Frank M. Kamer, M.D.'s co-authored study on the benefits of the use of fibrin glue adherent in facelift surgery has been published in the September issue of world's premier Plastic and Reconstructive Surgery Journal, that of the American Society of Plastic Surgeons. The study represents the most comprehensive clinical assessment of the use of fibrin glue in facelifts to date and its conclusions demonstrate a significant advancement in surgical facelift technique.

The study was conducted at the venerated Lasky Clinic in Beverly Hills, one of the first accredited outpatient ambulatory surgical centers in greater Los Angeles, founded by Dr. Frank Kamer in 1981. Dr. Nguyen and Dr. Kamer analyzed two hundred patients undergoing elective facelifts in a consistent fashion. One hundred patients over a one year period received fibrin glue during facelift surgery and their healing was measured prospectively. Another one hundred patients from the previous year who had not received fibrin glue had their charts retrospectively reviewed. All patients underwent facelifts by the same surgeon using the deep plane technique, which involves repositioning large skin flaps at multiple levels of the face. Patient healing was evaluated in stages at 24 hours, 48 hours, 1 week, 1 month, and 3 months postoperatively.

The use of fibrin glue was associated with several significant benefits in both the short and long-term healing processes of the patients studied. Fibrin glue alleviated the need for drainage tubes postoperatively that can cause discomfort. The tubes are normally placed under the skin for 1-2 days following facelift surgery to collect blood and prevent swelling. The fibrin glue adherent, which is applied before the external skin flap is resealed, also reduced the incidence of severe complications such as hematoma, seroma, and death. Most notably, zero percent of patients who received fibrin glue suffered prolonged swelling, discoloration, or hardness as opposed to twenty-two percent of patients who had not received fibrin glue.

Fibrin Tissue adhesive dates back to World War I when it was used topically to control the bleeding of wounded soldiers. Since then, it has been utilized with success in a variety of surgical procedures. It has been approved by the US Food and Drug Administration for colostomy procedure, cardiopulmonary bypass, and splenic surgery. Its use in aesthetic surgery, though popular in Europe, has been less widespread in the United States. Dr. Davis Nguyen, former chief surgical resident at Yale University, is among the few facial plastic surgeons employing this advanced facelift technique. "This advancement has had a tremendous impact on my practice," states Nguyen. "The major concerns for my patients are results, risk, and downtime. With this technique, my patients benefit from shorter recovery periods, fewer complications, and superior surgical outcomes."

ABOUT Dr. Davis B. Nguyen -- Dr. Nguyen is dual Board Certified in Facial Plastics and Otolaryngology. He currently practices in Beverly Hills, California where he focuses on the specialty of facial plastic and reconstructive surgery. He graduated from the University of California (UCLA), Summa Cum Laude, attended medical school at The University of Rochester as a Whipple Scholarship recipient, completed a research fellowship in General Surgery at Harvard Medical School, and conducted his surgical residency at Yale University. He is an instructor at the USC School of Medicine and has presented several papers at both national and international surgical conferences. For more information visit http://www.drdavisnguyen.com

Contact:

Jessica Inserra

310.550.0288

jessicainserra@hotmail.com


'/>"/>
SOURCE Dr. Davis B. Nguyen, M.D.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- ...
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology: